VEGF stimulates MAPK through a pathway that is unique for receptor tyrosine kinases

被引:94
作者
Doanes, AM
Hegland, DD
Sethi, R
Kovesdi, I
Bruder, JT
Finkel, T
机构
[1] NHLBI, Cardiol Branch, NIH, Bethesda, MD 20892 USA
[2] Gen Vec Inc, Rockville, MD USA
关键词
D O I
10.1006/bbrc.1999.0227
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We demonstrate that stimulation of primary cultures of endothelial cells with vascular endothelial cell growth factor (VEGF) results in a rapid increase in labeled guanine nucleotide bound to p21ras. Surprisingly, although VEGF stimulates ras activity, adenoviral-mediated gene transfer of a dominant negative form of ras (N17ras) had no effect on VEGF-stimulated mitogen-activated protein kinase (MAPK) activity. In contrast, treatment of endothelial cells with two structurally unrelated inhibitors of protein kinase C (PKC) abrogated VEGF-stimulated MAPK activity. In addition, inhibition of ras-Raf interactions by expression of a truncated form of Raf containing only the ras binding domain blocked VEGF-stimulated MAPK activation. These results suggest that VEGF stimulation of MAPK in endothelial cells differs from the pathway used by other members of the receptor tyrosine kinase family. In contrast, analogous to certain G-coupled receptors, VEGF appears to activate MAPK through a PKC-dependent pathway that requires a stable ras-Raf interaction but is not inhibited by N17ras expression. (C) 1999 Academic Press.
引用
收藏
页码:545 / 548
页数:4
相关论文
共 24 条
  • [1] DAngelo G, 1997, J CELL BIOCHEM, V67, P353, DOI 10.1002/(SICI)1097-4644(19971201)67:3<353::AID-JCB7>3.0.CO
  • [2] 2-V
  • [3] ACTIVATION OF MITOGEN-ACTIVATED PROTEIN-KINASES BY VASCULAR ENDOTHELIAL GROWTH-FACTOR AND BASIC FIBROBLAST GROWTH-FACTOR IN CAPILLARY ENDOTHELIAL-CELLS IS INHIBITED BY THE ANTIANGIOGENIC FACTOR 16-KDA N-TERMINAL FRAGMENT OF PROLACTIN
    DANGELO, G
    STRUMAN, I
    MARTIAL, J
    WEINER, RI
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (14) : 6374 - 6378
  • [4] INVOLVEMENT OF P21RAS IN ACTIVATION OF EXTRACELLULAR SIGNAL-REGULATED KINASE-2
    DEVRIESSMITS, AMM
    BURGERING, BMT
    LEEVERS, SJ
    MARSHALL, CJ
    BOS, JL
    [J]. NATURE, 1992, 357 (6379) : 602 - 604
  • [5] DEVRIESSMITS AMM, 1995, METHOD ENZYMOL, V255, P156
  • [6] SOLUTION STRUCTURE OF THE RAS-BINDING DOMAIN OF C-RAF-1 AND IDENTIFICATION OF ITS RAS INTERACTION SURFACE
    EMERSON, SD
    MADISON, VS
    PALERMO, RE
    WAUGH, DS
    SCHEFFLER, JE
    TSAO, KL
    KIEFER, SE
    LIU, SP
    FRY, DC
    [J]. BIOCHEMISTRY, 1995, 34 (21) : 6911 - 6918
  • [7] The biology of vascular endothelial growth factor
    Ferrara, N
    DavisSmyth, T
    [J]. ENDOCRINE REVIEWS, 1997, 18 (01) : 4 - 25
  • [8] ANGIOGENESIS IN CANCER, VASCULAR, RHEUMATOID AND OTHER DISEASE
    FOLKMAN, J
    [J]. NATURE MEDICINE, 1995, 1 (01) : 27 - 31
  • [9] VASCULAR ENDOTHELIAL-CELL GROWTH-FACTOR PROMOTES TYROSINE PHOSPHORYLATION OF MEDIATORS OF SIGNAL-TRANSDUCTION THAT CONTAIN SH2 DOMAINS - ASSOCIATION WITH ENDOTHELIAL-CELL PROLIFERATION
    GUO, DQ
    JIA, Q
    SONG, HY
    WARREN, RS
    DONNER, DB
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (12) : 6729 - 6733
  • [10] IN-VIVO SUPPRESSION OF INJURY-INDUCED VASCULAR SMOOTH-MUSCLE CELL ACCUMULATION USING ADENOVIRUS-MEDIATED TRANSFER OF THE HERPES-SIMPLEX VIRUS THYMIDINE KINASE GENE
    GUZMAN, RJ
    HIRSCHOWITZ, EA
    BRODY, SL
    CRYSTAL, RG
    EPSTEIN, SE
    FINKEL, T
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (22) : 10732 - 10736